Open Your FREE Demat Account Now!

Everest Organics Ltd. Share Price

NSE
BSE

BSE : 524790

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹227.65
Day's Range ₹214.05 - ₹237.00
Open ₹226.65
52 Week Range ₹197.00 - ₹536.40
Volume 1,232
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 2.81
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 43.21
TTM EPS (₹) 5.27
P/E Ratio 0.00
Book Value(₹) 2.82
PAT Margin (%) -0.71
Face Value (₹) 10.00
ROCE(%) 1.76

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 538.13 1594.79
Expenses N/A N/A
PBT 21.65 -32.42
Operating profit 0.0 0.0
Net profit 14.05 -12.9

Shareholding Pattern

Promoters (% Holding)

60.61%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

39.37%

FI/Banks/Insurance (% Holding)

0.02%

Government (% Holding)

0.00%

FII

0.00%

About Everest Organics Ltd.

Founded 1993
Managing Director Sri Kakarlapudi Sirisha

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,22,282.95 1,760.00 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,44,762.03 9,220.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,73,447.74 4,560.00 3,505.50 - 3,505.50
Apollo Hospitals Enterprise Ltd. 1,13,546.74 7,897.00 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,12,420.05 648.25 0.00 - 0.00
Zydus Lifesciences Ltd. 1,12,149.36 1,124.30 835.50 - 835.50
Laurus Labs Ltd. 1,11,250.29 2,059.00 870.45 - 870.45
Cipla Ltd. 1,07,042.86 1,325.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,02,820.09 1,231.85 1,101.00 - 1,101.00
Aurobindo Pharma Ltd. 95,512.73 1,658.65 1,080.10 - 1,080.10
no-content No Records Found

Latest News

Aug
17
2026
EQUITY Posted on Aug 17th 2026

Everest Organics informs about newspaper publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has enclosed copies of the newspaper advertisement published by the Company on Saturday, August 15, 2026, in the following newspapers, intimating the publication of the Company's unaudited Standalone Financial Results for the quarter ended June 30, 2026: 1. The South India Times (English), 2. Telugu Prabha (Regional).
The above information is a part of company’s filings submitted to BSE.  
Read More
Oct
17
2026
EQUITY Posted on Oct 17th 2026

Acutaas Chemicals informs about updates on acquisition

With reference to earlier intimation dated September 24, 2026, and pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Acutaas Chemicals has informed that that the Company has completed the acquisition of 100% of the equity share capital of Enchem Ami Organics, a step-down subsidiary of the Company, through the transfer of 10,000 equity shares of face value of Rs 10 each from Acutaas Chemicals Electrolytes, a subsidiary of the Company. Consequent to the completion of the aforesaid acquisition on October 17, 2026, Enchem Ami Organics has become a direct wholly-owned subsidiary of the Company. The above information is also being made available on the website of the Company at www.acutaas.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
17
2026
EQUITY Posted on Oct 17th 2026

Shalby informs about company updates

With reference to earlier intimation regarding the temporary suspension of registration of Shalby Hospital, Jabalpur due to minor fire incident occurred at one of the floors on October 11, 2026, Shalby has informed that pursuant to regulation 30 of SEBI LODR, the Company has received a communication letter dated October 17, 2026 from the Office of the Chief Medical and Health Officer (CMHO), Jabalpur, permitting the hospital to resume its normal operations. Accordingly, the hospital is permitted to resume its regular healthcare services, including the admission of patients, subject to the conditions stipulated by the competent authority. However, the affected floor shall remain non‐operational until completion of the requisite renovation work, reassessment and receipt of the necessary clearance from the competent authority. The Company remains committed to ensuring patient safety as top priority and prime responsibilities, complying with all applicable regulatory requirements and maintaining continuity of healthcare services. The details required under Reg. 30 read with Part A of Schedule III of Listing Regulations are provided in attached Annexure.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
17
2026
EQUITY Posted on Oct 17th 2026

Trident Lifeline informs about newspaper publication

Trident Lifeline has attached copies of the newspaper advertisements published in Financial Express (English) and Financial Express (Gujarati) regarding the corrigendum to the Notice of the Extra-Ordinary General Meeting (EGM), pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The above information is also available on the website of the Company www.tridentlifeline.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
17
2026
EQUITY Posted on Oct 17th 2026

Viyash Scientific informs about disclosure

Viyash Scientific has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for White Oak Capital Management Consultants LLP.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Everest Organics Ltd. ?

The current share price of Everest Organics Ltd. is ₹227.65 as of 2026-10-16.

The market capitalisation of Everest Organics Ltd. is ₹227.05 as of 2026-10-16.

The 1-year return of Everest Organics Ltd. is -182.35% as of 2026-10-16.

The P/E ratio of Everest Organics Ltd. is 0.00 as of 2026-10-17.

The 52-week high and low of Everest Organics Ltd. are ₹536.40 and ₹197.00, respectively, as of 2026-10-16.

The dividend yield of Everest Organics Ltd. is 0.0% as of2026-10-16.

You can buy Everest Organics Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Everest Organics Ltd. is Sri Kakarlapudi Sirisha.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore